Skip to main content
Senate Bill 0272


Senate Bill 0272

ARCHIVE (2013)

Latest Information

 

DIGEST OF SB 272 (Updated April 15, 2013 4:55 pm - DI 84)


Prescription products. Allows a pharmacist to substitute an interchangeable biosimilar product for a prescribed biological product if certain conditions are met. Requires the board of pharmacy to maintain an Internet web site that lists the biosimilar biological products that are determined to be interchangeable. Allows the board of pharmacy to adopt rules. Provides that a written or electronic prescription for a biological product must comply with the existing prescription form requirements. Requires, during the 2013 legislative interim: (1) the division of mental health and addiction to provide the health finance commission with specified information concerning opioid treatment programs; and (2) the health finance commission to study how Indiana law may affect the prescribing and substituting of biosimilar biological products.
    Current Status:
     Returned to House of origin with Amendments
    >Latest Printing > (PDF)